UniProtKB - Q06413 (MEF2C_HUMAN)
Myocyte-specific enhancer factor 2C
MEF2C
Functioni
Transcription activator which binds specifically to the MEF2 element present in the regulatory regions of many muscle-specific genes. Controls cardiac morphogenesis and myogenesis, and is also involved in vascular development. Enhances transcriptional activation mediated by SOX18. Plays an essential role in hippocampal-dependent learning and memory by suppressing the number of excitatory synapses and thus regulating basal and evoked synaptic transmission. Crucial for normal neuronal development, distribution, and electrical activity in the neocortex. Necessary for proper development of megakaryocytes and platelets and for bone marrow B-lymphopoiesis. Required for B-cell survival and proliferation in response to BCR stimulation, efficient IgG1 antibody responses to T-cell-dependent antigens and for normal induction of germinal center B-cells. May also be involved in neurogenesis and in the development of cortical architecture (By similarity).
Isoforms that lack the repressor domain are more active than isoform 1.
By similarity6 PublicationsRegions
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
DNA bindingi | 58 – 86 | Mef2-typeSequence analysisAdd BLAST | 29 |
GO - Molecular functioni
- DNA binding Source: UniProtKB
- DNA-binding transcription activator activity, RNA polymerase II-specific Source: UniProtKB
- DNA-binding transcription factor activity Source: BHF-UCL
- DNA-binding transcription factor activity, RNA polymerase II-specific Source: UniProtKB
- DNA-binding transcription factor binding Source: UniProtKB
- histone deacetylase binding Source: GO_Central
- minor groove of adenine-thymine-rich DNA binding Source: UniProtKB
- protein heterodimerization activity Source: UniProtKB
- RNA polymerase II cis-regulatory region sequence-specific DNA binding Source: GO_Central
- RNA polymerase II-specific DNA-binding transcription factor binding Source: BHF-UCL
- RNA polymerase II transcription regulatory region sequence-specific DNA binding Source: UniProtKB
- sequence-specific double-stranded DNA binding Source: ARUK-UCL
- transcription cis-regulatory region binding Source: BHF-UCL
GO - Biological processi
- apoptotic process Source: UniProtKB-KW
- B cell homeostasis Source: UniProtKB
- B cell proliferation Source: UniProtKB
- B cell receptor signaling pathway Source: UniProtKB
- blood vessel development Source: UniProtKB
- blood vessel remodeling Source: UniProtKB
- cardiac ventricle formation Source: UniProtKB
- cell differentiation Source: GO_Central
- cell morphogenesis involved in neuron differentiation Source: Alzheimers_University_of_Toronto
- cellular response to calcium ion Source: UniProtKB
- cellular response to fluid shear stress Source: UniProtKB
- cellular response to lipopolysaccharide Source: UniProtKB
- cellular response to parathyroid hormone stimulus Source: UniProtKB
- cellular response to transforming growth factor beta stimulus Source: UniProtKB
- cellular response to trichostatin A Source: UniProtKB
- cellular response to xenobiotic stimulus Source: UniProtKB
- chondrocyte differentiation Source: UniProtKB
- endochondral ossification Source: UniProtKB
- epithelial cell proliferation involved in renal tubule morphogenesis Source: UniProtKB
- excitatory postsynaptic potential Source: Alzheimers_University_of_Toronto
- germinal center formation Source: UniProtKB
- glomerulus morphogenesis Source: UniProtKB
- heart development Source: UniProtKB
- heart looping Source: UniProtKB
- humoral immune response Source: UniProtKB
- learning or memory Source: UniProtKB
- MAPK cascade Source: UniProtKB
- melanocyte differentiation Source: UniProtKB
- muscle cell fate determination Source: UniProtKB
- muscle organ development Source: ProtInc
- myotube differentiation Source: UniProtKB
- negative regulation of blood vessel endothelial cell migration Source: BHF-UCL
- negative regulation of gene expression Source: UniProtKB
- negative regulation of neuron apoptotic process Source: UniProtKB
- negative regulation of ossification Source: UniProtKB
- negative regulation of transcription by RNA polymerase II Source: BHF-UCL
- negative regulation of vascular associated smooth muscle cell migration Source: BHF-UCL
- negative regulation of vascular associated smooth muscle cell proliferation Source: BHF-UCL
- negative regulation of vascular endothelial cell proliferation Source: BHF-UCL
- nephron tubule epithelial cell differentiation Source: UniProtKB
- nervous system development Source: ProtInc
- neural crest cell differentiation Source: UniProtKB
- neuron development Source: UniProtKB
- neuron differentiation Source: UniProtKB
- neuron migration Source: Alzheimers_University_of_Toronto
- osteoblast differentiation Source: UniProtKB
- outflow tract morphogenesis Source: UniProtKB
- platelet formation Source: UniProtKB
- positive regulation of alkaline phosphatase activity Source: UniProtKB
- positive regulation of B cell proliferation Source: UniProtKB
- positive regulation of behavioral fear response Source: UniProtKB
- positive regulation of bone mineralization Source: UniProtKB
- positive regulation of cardiac muscle cell differentiation Source: UniProtKB
- positive regulation of cardiac muscle cell proliferation Source: UniProtKB
- positive regulation of gene expression Source: UniProtKB
- positive regulation of macrophage apoptotic process Source: UniProtKB
- positive regulation of MAP kinase activity Source: Alzheimers_University_of_Toronto
- positive regulation of myoblast differentiation Source: UniProtKB
- positive regulation of neuron differentiation Source: UniProtKB
- positive regulation of osteoblast differentiation Source: UniProtKB
- positive regulation of skeletal muscle cell differentiation Source: UniProtKB
- positive regulation of skeletal muscle tissue development Source: UniProtKB
- positive regulation of transcription, DNA-templated Source: UniProtKB
- positive regulation of transcription by RNA polymerase II Source: UniProtKB
- primary heart field specification Source: UniProtKB
- regulation of AMPA receptor activity Source: Alzheimers_University_of_Toronto
- regulation of dendritic spine development Source: Alzheimers_University_of_Toronto
- regulation of germinal center formation Source: UniProtKB
- regulation of megakaryocyte differentiation Source: UniProtKB
- regulation of neuron apoptotic process Source: Alzheimers_University_of_Toronto
- regulation of neurotransmitter secretion Source: Alzheimers_University_of_Toronto
- regulation of NMDA receptor activity Source: Alzheimers_University_of_Toronto
- regulation of synapse assembly Source: Alzheimers_University_of_Toronto
- regulation of synaptic activity Source: UniProtKB
- regulation of synaptic plasticity Source: Alzheimers_University_of_Toronto
- regulation of synaptic transmission, glutamatergic Source: Alzheimers_University_of_Toronto
- regulation of transcription, DNA-templated Source: Alzheimers_University_of_Toronto
- regulation of transcription by RNA polymerase II Source: GO_Central
- renal tubule morphogenesis Source: UniProtKB
- response to ischemia Source: Alzheimers_University_of_Toronto
- secondary heart field specification Source: UniProtKB
- sinoatrial valve morphogenesis Source: UniProtKB
- skeletal muscle tissue development Source: UniProtKB
- smooth muscle cell differentiation Source: UniProtKB
- ventricular cardiac muscle cell differentiation Source: UniProtKB
Keywordsi
Molecular function | Activator, Developmental protein, DNA-binding |
Biological process | Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation |
Enzyme and pathway databases
PathwayCommonsi | Q06413 |
Reactomei | R-HSA-198753, ERK/MAPK targets R-HSA-2151201, Transcriptional activation of mitochondrial biogenesis R-HSA-400253, Circadian Clock R-HSA-525793, Myogenesis R-HSA-9022707, MECP2 regulates transcription factors R-HSA-9707616, Heme signaling |
SignaLinki | Q06413 |
SIGNORi | Q06413 |
Names & Taxonomyi
Protein namesi | Recommended name: Myocyte-specific enhancer factor 2CCuratedAlternative name(s): Myocyte enhancer factor 2CImported |
Gene namesi | Name:MEF2CImported |
Organismi | Homo sapiens (Human) |
Taxonomic identifieri | 9606 [NCBI] |
Taxonomic lineagei | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Proteomesi |
|
Organism-specific databases
HGNCi | HGNC:6996, MEF2C |
MIMi | 600662, gene |
neXtProti | NX_Q06413 |
VEuPathDBi | HostDB:ENSG00000081189 |
Subcellular locationi
Nucleus
- Nucleus By similarity
Other locations
- sarcoplasm By similarity
Cytosol
- cytosol Source: Alzheimers_University_of_Toronto
Nucleus
- nuclear speck Source: BHF-UCL
- nucleoplasm Source: HPA
- nucleus Source: UniProtKB
Other locations
- chromatin Source: NTNU_SB
- cytoplasm Source: UniProtKB
- intracellular membrane-bounded organelle Source: HPA
- postsynapse Source: GOC
- protein-containing complex Source: UniProtKB
- sarcoplasm Source: UniProtKB-SubCell
Keywords - Cellular componenti
Cytoplasm, NucleusPathology & Biotechi
Involvement in diseasei
Mental retardation, autosomal dominant 20 (MRD20)1 Publication
Mutagenesis
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Mutagenesisi | 116 | K → R: Reduced acetylation. Further reduction in acetylation; when associated with R-119. Complete loss of acetylation, 15% less transactivation activity and slightly reduced DNA binding; when associated with R-119; R-234; R-239; R-252 and R-262. 1 Publication | 1 | |
Mutagenesisi | 119 | K → R: Reduced acetylation. Further reduction in acetylation; when associated with R-119. Complete loss of acetylation, 15% less transactivation activity and slightly reduced DNA binding; when associated with R-116; R-234; R-239; R-252 and R-262. 1 Publication | 1 | |
Mutagenesisi | 234 | K → R: Reduced acetylation. Complete loss of acetylation, 15% less transactivation activity and slightly reduced DNA binding; when associated with R-116; R-119; R-239; R-252 and R-264. 1 Publication | 1 | |
Mutagenesisi | 239 | K → R: Reduced acetylation. Complete loss of acetylation, 15% less transactivation activity and slightly reduced DNA binding; when associated with R-116; R-119; R-234; R-252 and R-264. 1 Publication | 1 | |
Mutagenesisi | 252 | K → R: Reduced acetylation. Complete loss of acetylation, 15% less transactivation activity and slightly reduced DNA binding; when associated with R-116; R-119; R-234; R-239 and R-264. 1 Publication | 1 | |
Mutagenesisi | 264 | K → R: Reduced acetylation. Complete loss of acetylation, 15% less transactivation activity and slightly reduced DNA binding; when associated with R-116; R-119; R-234; R-239 and R-252. 1 Publication | 1 | |
Mutagenesisi | 271 | S → A: No effect on transcriptional activation. 1 Publication | 1 | |
Mutagenesisi | 272 | E → Q: Reduced transcriptional activation. Completely abolishes transcriptional activation; when associated with N-273 and N-275. 1 Publication | 1 | |
Mutagenesisi | 273 | D → N: Reduced transcriptional activation. Completely abolishes transcriptional activation; when associated with Q-272 and N-275. 1 Publication | 1 | |
Mutagenesisi | 275 | D → N: Reduced transcriptional activation. Completely abolishes transcriptional activation; when associated with Q-272 and N-273. 1 Publication | 1 | |
Mutagenesisi | 293 | T → A: Abolishes MAPK14-mediated phosphorylation. No effect on MAPK7-mediated phosphorylation; when associated with A-300. 2 Publications | 1 | |
Mutagenesisi | 300 | T → A: Abolishes MAPK14-mediated phosphorylation. No effect on MAPK7-mediated phosphorylation; when associated with A-293. 2 Publications | 1 | |
Mutagenesisi | 387 | S → A: No change in transactivational activation for isoforms with or without the beta domain. 1 Publication | 1 | |
Mutagenesisi | 391 | K → R: Abolishes sumoylation. 1 Publication | 1 | |
Mutagenesisi | 396 | S → A or C: Abolishes sumoylation. Enhanced transcriptional activity. 3 Publications | 1 | |
Mutagenesisi | 396 | S → A: No change in transactivational activation for isoforms with or without the beta domain. 3 Publications | 1 | |
Mutagenesisi | 396 | S → E: No effect on sumoylation. No effect on transcriptional activity. 3 Publications | 1 | |
Mutagenesisi | 419 | S → A: No effect on MAPK14-mediated phosphorylation. Abolishes MAPK7-mediated phosphorylation and reduces transactivation activity. 2 Publications | 1 | |
Mutagenesisi | 432 | D → A: Abolishes cleavage by caspase 7. 1 Publication | 1 |
Keywords - Diseasei
Disease variant, Epilepsy, Mental retardationOrganism-specific databases
DisGeNETi | 4208 |
MalaCardsi | MEF2C |
MIMi | 613443, phenotype |
OpenTargetsi | ENSG00000081189 |
Orphaneti | 228384, 5q14.3 microdeletion syndrome |
PharmGKBi | PA30734 |
Miscellaneous databases
Pharosi | Q06413, Tbio |
Genetic variation databases
BioMutai | MEF2C |
DMDMi | 2500875 |
PTM / Processingi
Molecule processing
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
ChainiPRO_0000199433 | 1 – 473 | Myocyte-specific enhancer factor 2CAdd BLAST | 473 |
Amino acid modifications
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Modified residuei | 4 | N6-acetyllysineBy similarity | 1 | |
Modified residuei | 59 | Phosphoserine; by CK2By similarity | 1 | |
Modified residuei | 98 | PhosphoserineBy similarity | 1 | |
Modified residuei | 106 | PhosphoserineBy similarity | 1 | |
Modified residuei | 110 | PhosphoserineBy similarity | 1 | |
Modified residuei | 116 | N6-acetyllysine1 Publication | 1 | |
Modified residuei | 119 | N6-acetyllysine1 Publication | 1 | |
Modified residuei | 222 | PhosphoserineCombined sources | 1 | |
Modified residuei | 228 | PhosphoserineCombined sources | 1 | |
Modified residuei | 234 | N6-acetyllysine1 Publication | 1 | |
Modified residuei | 239 | N6-acetyllysine1 Publication | 1 | |
Modified residuei | 240 | PhosphoserineCombined sources | 1 | |
Modified residuei | 252 | N6-acetyllysine1 Publication | 1 | |
Modified residuei | 264 | N6-acetyllysine1 Publication | 1 | |
Modified residuei | 293 | Phosphothreonine; by MAPK142 Publications | 1 | |
Modified residuei | 300 | Phosphothreonine; by MAPK142 Publications | 1 | |
Cross-linki | 391 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)2 Publications | ||
Modified residuei | 396 | Phosphoserine; by CDK51 Publication | 1 | |
Modified residuei | 419 | Phosphoserine; by MAPK72 Publications | 1 | |
Modified residuei | 445 | PhosphoserineCombined sources | 1 |
Post-translational modificationi
Sites
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Sitei | 432 – 433 | CleavageCurated | 2 |
Keywords - PTMi
Acetylation, Isopeptide bond, Phosphoprotein, Ubl conjugationProteomic databases
jPOSTi | Q06413 |
MassIVEi | Q06413 |
MaxQBi | Q06413 |
PeptideAtlasi | Q06413 |
PRIDEi | Q06413 |
ProteomicsDBi | 10911 30019 58439 [Q06413-1] 58440 [Q06413-2] 58441 [Q06413-3] 58442 [Q06413-4] |
PTM databases
GlyGeni | Q06413, 1 site, 1 O-linked glycan (1 site) |
iPTMneti | Q06413 |
PhosphoSitePlusi | Q06413 |
Expressioni
Tissue specificityi
Developmental stagei
Gene expression databases
Bgeei | ENSG00000081189, Expressed in middle temporal gyrus and 242 other tissues |
ExpressionAtlasi | Q06413, baseline and differential |
Genevisiblei | Q06413, HS |
Organism-specific databases
HPAi | ENSG00000081189, Group enriched (skeletal muscle, tongue) |
Interactioni
Subunit structurei
Forms a complex with class II HDACs in undifferentiating cells. On myogenic differentiation, HDACs are released into the cytoplasm allowing MEF2s to interact with other proteins for activation.
Interacts with EP300 in differentiating cells; the interaction acetylates MEF2C leading to increased DNA binding and activation (By similarity).
Interacts with HDAC7 and CARM1 (By similarity).
Interacts with HDAC4 and HDAC9; the interaction with HDACs represses transcriptional activity (PubMed:10523670, PubMed:11535832).
Interacts with LPIN1.
Interacts with MYOCD.
Interacts with AKAP13 (By similarity).
Interacts with FOXK1; the interaction inhibits MEF2C transactivation activity (By similarity).
Interacts (via N-terminus) with HABP4; this interaction decreases DNA-binding activity of MEF2C in myocardial cells in response to mechanical stress (PubMed:15862299).
Interacts with JPH2; interaction specifically takes place with the Junctophilin-2 N-terminal fragment cleavage product of JPH2 (By similarity).
Interacts (via MADS box) with SOX18 (By similarity).
By similarity3 PublicationsBinary interactionsi
Q06413
GO - Molecular functioni
- DNA-binding transcription factor binding Source: UniProtKB
- histone deacetylase binding Source: GO_Central
- protein heterodimerization activity Source: UniProtKB
- RNA polymerase II-specific DNA-binding transcription factor binding Source: BHF-UCL
Protein-protein interaction databases
BioGRIDi | 110372, 32 interactors |
DIPi | DIP-40857N |
ELMi | Q06413 |
IntActi | Q06413, 26 interactors |
MINTi | Q06413 |
STRINGi | 9606.ENSP00000340874 |
Miscellaneous databases
RNActi | Q06413, protein |
Family & Domainsi
Domains and Repeats
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Domaini | 3 – 57 | MADS-boxPROSITE-ProRule annotationAdd BLAST | 55 |
Region
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Regioni | 91 – 116 | DisorderedSequence analysisAdd BLAST | 26 | |
Regioni | 180 – 224 | DisorderedSequence analysisAdd BLAST | 45 | |
Regioni | 271 – 278 | Beta domain | 8 | |
Regioni | 368 – 399 | Transcription repressorAdd BLAST | 32 | |
Regioni | 375 – 473 | DisorderedSequence analysisAdd BLAST | 99 |
Compositional bias
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Compositional biasi | 93 – 116 | Basic and acidic residuesSequence analysisAdd BLAST | 24 | |
Compositional biasi | 375 – 405 | Polar residuesSequence analysisAdd BLAST | 31 |
Domaini
Sequence similaritiesi
Phylogenomic databases
eggNOGi | KOG0014, Eukaryota |
GeneTreei | ENSGT00940000157492 |
InParanoidi | Q06413 |
OMAi | RITEGWA |
OrthoDBi | 729387at2759 |
PhylomeDBi | Q06413 |
TreeFami | TF314067 |
Family and domain databases
CDDi | cd00265, MADS_MEF2_like, 1 hit |
Gene3Di | 3.40.1810.10, 1 hit |
InterProi | View protein in InterPro IPR022102, HJURP_C IPR033896, MADS_MEF2-like IPR002100, TF_MADSbox IPR036879, TF_MADSbox_sf |
Pfami | View protein in Pfam PF12347, HJURP_C, 1 hit PF00319, SRF-TF, 1 hit |
PRINTSi | PR00404, MADSDOMAIN |
SMARTi | View protein in SMART SM00432, MADS, 1 hit |
SUPFAMi | SSF55455, SSF55455, 1 hit |
PROSITEi | View protein in PROSITE PS00350, MADS_BOX_1, 1 hit PS50066, MADS_BOX_2, 1 hit |
s (6+)i Sequence
Sequence statusi: Complete.
This entry describes 6 produced by isoformsialternative splicing. AlignAdd to basketThis entry has 6 described isoforms and 20 potential isoforms that are computationally mapped.Show allAlign All
This isoform has been chosen as the sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. canonicali
10 20 30 40 50
MGRKKIQITR IMDERNRQVT FTKRKFGLMK KAYELSVLCD CEIALIIFNS
60 70 80 90 100
TNKLFQYAST DMDKVLLKYT EYNEPHESRT NSDIVETLRK KGLNGCDSPD
110 120 130 140 150
PDADDSVGHS PESEDKYRKI NEDIDLMISR QRLCAVPPPN FEMPVSIPVS
160 170 180 190 200
SHNSLVYSNP VSSLGNPNLL PLAHPSLQRN SMSPGVTHRP PSAGNTGGLM
210 220 230 240 250
GGDLTSGAGT SAGNGYGNPR NSPGLLVSPG NLNKNMQAKS PPPMNLGMNN
260 270 280 290 300
RKPDLRVLIP PGSKNTMPSV SEDVDLLLNQ RINNSQSAQS LATPVVSVAT
310 320 330 340 350
PTLPGQGMGG YPSAISTTYG TEYSLSSADL SSLSGFNTAS ALHLGSVTGW
360 370 380 390 400
QQQHLHNMPP SALSQLGACT STHLSQSSNL SLPSTQSLNI KSEPVSPPRD
410 420 430 440 450
RTTTPSRYPQ HTRHEAGRSP VDSLSSCSSS YDGSDREDHR NEFHSPIGLT
460 470
RPSPDERESP SVKRMRLSEG WAT
Computationally mapped potential isoform sequencesi
There are 20 potential isoforms mapped to this entry.BLASTAlignShow allAdd to basketA0A0D9SGI5 | A0A0D9SGI5_HUMAN | Myocyte-specific enhancer factor 2C | MEF2C | 471 | Annotation score: | ||
D6RJG6 | D6RJG6_HUMAN | Myocyte-specific enhancer factor 2C | MEF2C | 399 | Annotation score: | ||
A0A0R4J2G5 | A0A0R4J2G5_HUMAN | Myocyte-specific enhancer factor 2C | MEF2C | 433 | Annotation score: | ||
A0A0D9SFD0 | A0A0D9SFD0_HUMAN | MADS box transcription enhancer fac... | MEF2C hCG_36839 | 431 | Annotation score: | ||
A0A1B0GV32 | A0A1B0GV32_HUMAN | Myocyte-specific enhancer factor 2C | MEF2C | 462 | Annotation score: | ||
D8L7E9 | D8L7E9_HUMAN | Myocyte enhancer factor 2c | MEF2C | 393 | Annotation score: | ||
D6RCM6 | D6RCM6_HUMAN | Myocyte-specific enhancer factor 2C | MEF2C | 129 | Annotation score: | ||
D6RG21 | D6RG21_HUMAN | Myocyte-specific enhancer factor 2C | MEF2C | 126 | Annotation score: | ||
D6RJA7 | D6RJA7_HUMAN | Myocyte-specific enhancer factor 2C | MEF2C | 194 | Annotation score: | ||
D6R942 | D6R942_HUMAN | Myocyte-specific enhancer factor 2C | MEF2C | 227 | Annotation score: | ||
There are more potential isoformsShow all |
Experimental Info
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Sequence conflicti | 390 | I → T in AL833268 (PubMed:17974005).Curated | 1 |
Natural variant
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Natural variantiVAR_078228 | 36 | S → R Probable disease-associated variant found in a patient with infantile onset epileptic encephalopathy and autism spectrum disorder. 1 Publication | 1 | |
Natural variantiVAR_078621 | 39 | C → R Probable disease-associated variant found in a patient with infantile onset epileptic encephalopathy and autism spectrum disorder. 1 PublicationCorresponds to variant dbSNP:rs796052729EnsemblClinVar. | 1 |
Alternative sequence
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Alternative sequenceiVSP_043339 | 87 – 134 | Missing in isoform 4. 1 PublicationAdd BLAST | 48 | |
Alternative sequenceiVSP_046251 | 87 – 134 | TLRKK…RQRLC → ALNKKENKGCESPDPDSSYA LTPRTEEKYKKINEEFDNMI KSHKIP in isoform 6. 1 PublicationAdd BLAST | 48 | |
Alternative sequenceiVSP_045478 | 107 – 134 | VGHSP…RQRLC → ALNKKENKGCESPDPDSSYA LTPRTEEKYKKINEEFDNMI KSHKIP in isoform 5. 1 PublicationAdd BLAST | 28 | |
Alternative sequenceiVSP_006248 | 271 – 278 | Missing in isoform 2, isoform 4, isoform 5 and isoform 6. 4 Publications | 8 | |
Alternative sequenceiVSP_006249 | 368 – 399 | Missing in isoform 3. 1 PublicationAdd BLAST | 32 |
Sequence databases
Genome annotation databases
Keywords - Coding sequence diversityi
Alternative splicingSimilar proteinsi
Cross-referencesi
Sequence databases
3D structure databases
SMRi | Q06413 |
ModBasei | Search... |
Protein-protein interaction databases
BioGRIDi | 110372, 32 interactors |
DIPi | DIP-40857N |
ELMi | Q06413 |
IntActi | Q06413, 26 interactors |
MINTi | Q06413 |
STRINGi | 9606.ENSP00000340874 |
PTM databases
GlyGeni | Q06413, 1 site, 1 O-linked glycan (1 site) |
iPTMneti | Q06413 |
PhosphoSitePlusi | Q06413 |
Genetic variation databases
BioMutai | MEF2C |
DMDMi | 2500875 |
Proteomic databases
jPOSTi | Q06413 |
MassIVEi | Q06413 |
MaxQBi | Q06413 |
PeptideAtlasi | Q06413 |
PRIDEi | Q06413 |
ProteomicsDBi | 10911 30019 58439 [Q06413-1] 58440 [Q06413-2] 58441 [Q06413-3] 58442 [Q06413-4] |
Protocols and materials databases
Antibodypediai | 755, 1307 antibodies from 36 providers |
DNASUi | 4208 |
Genome annotation databases
Organism-specific databases
CTDi | 4208 |
DisGeNETi | 4208 |
GeneCardsi | MEF2C |
HGNCi | HGNC:6996, MEF2C |
HPAi | ENSG00000081189, Group enriched (skeletal muscle, tongue) |
MalaCardsi | MEF2C |
MIMi | 600662, gene 613443, phenotype |
neXtProti | NX_Q06413 |
OpenTargetsi | ENSG00000081189 |
Orphaneti | 228384, 5q14.3 microdeletion syndrome |
PharmGKBi | PA30734 |
VEuPathDBi | HostDB:ENSG00000081189 |
GenAtlasi | Search... |
Phylogenomic databases
eggNOGi | KOG0014, Eukaryota |
GeneTreei | ENSGT00940000157492 |
InParanoidi | Q06413 |
OMAi | RITEGWA |
OrthoDBi | 729387at2759 |
PhylomeDBi | Q06413 |
TreeFami | TF314067 |
Enzyme and pathway databases
PathwayCommonsi | Q06413 |
Reactomei | R-HSA-198753, ERK/MAPK targets R-HSA-2151201, Transcriptional activation of mitochondrial biogenesis R-HSA-400253, Circadian Clock R-HSA-525793, Myogenesis R-HSA-9022707, MECP2 regulates transcription factors R-HSA-9707616, Heme signaling |
SignaLinki | Q06413 |
SIGNORi | Q06413 |
Miscellaneous databases
BioGRID-ORCSi | 4208, 31 hits in 1069 CRISPR screens |
ChiTaRSi | MEF2C, human |
GeneWikii | MEF2C |
GenomeRNAii | 4208 |
Pharosi | Q06413, Tbio |
PROi | PR:Q06413 |
RNActi | Q06413, protein |
SOURCEi | Search... |
Gene expression databases
Bgeei | ENSG00000081189, Expressed in middle temporal gyrus and 242 other tissues |
ExpressionAtlasi | Q06413, baseline and differential |
Genevisiblei | Q06413, HS |
Family and domain databases
CDDi | cd00265, MADS_MEF2_like, 1 hit |
Gene3Di | 3.40.1810.10, 1 hit |
InterProi | View protein in InterPro IPR022102, HJURP_C IPR033896, MADS_MEF2-like IPR002100, TF_MADSbox IPR036879, TF_MADSbox_sf |
Pfami | View protein in Pfam PF12347, HJURP_C, 1 hit PF00319, SRF-TF, 1 hit |
PRINTSi | PR00404, MADSDOMAIN |
SMARTi | View protein in SMART SM00432, MADS, 1 hit |
SUPFAMi | SSF55455, SSF55455, 1 hit |
PROSITEi | View protein in PROSITE PS00350, MADS_BOX_1, 1 hit PS50066, MADS_BOX_2, 1 hit |
MobiDBi | Search... |
Entry informationi
Entry namei | MEF2C_HUMAN | |
Accessioni | Q06413Primary (citable) accession number: Q06413 Secondary accession number(s): C9JMZ0, D7F7N5, F8W7V7 | |
Entry historyi | Integrated into UniProtKB/Swiss-Prot: | November 1, 1997 |
Last sequence update: | November 1, 1997 | |
Last modified: | February 23, 2022 | |
This is version 199 of the entry and version 1 of the sequence. See complete history. | ||
Entry statusi | Reviewed (UniProtKB/Swiss-Prot) | |
Annotation program | Chordata Protein Annotation Program | |
Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. |
Miscellaneousi
Keywords - Technical termi
Reference proteomeDocuments
- Human chromosome 5
Human chromosome 5: entries, gene names and cross-references to MIM - Human entries with genetic variants
List of human entries with genetic variants - Human variants curated from literature reports
Index of human variants curated from literature reports - MIM cross-references
Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot - SIMILARITY comments
Index of protein domains and families